SGB-3403

Suzhou Sanegene Bio Inc. · Phase 1 active Small molecule Quality 0/100

At a glance

Generic name	SGB-3403
Sponsor	Suzhou Sanegene Bio Inc.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C) (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

SGB-3403 CI brief — competitive landscape report
SGB-3403 updates RSS · CI watch RSS
Suzhou Sanegene Bio Inc. portfolio CI